XML 51 R37.htm IDEA: XBRL DOCUMENT v3.21.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2020
Share-based Payment Arrangement [Abstract]  
Summary of Stock Options Outstanding

Activity in the various Plans during the years ended December 31, 2020 and 2019 is reflected in the following table:

 

Options   Number of
Shares
    Weighted
Average
Exercise Price
 
Outstanding at January 1, 2019     434,012     $ 4.62  
Granted     180,000       3.01  
Exercised            
Forfeited     (24,887 )     (13.78 )
Outstanding at December 31, 2019     589,125     $ 3.74  
Exercisable at December 31, 2019     499,125     $ 3.87  

 

Options   Number of
Shares
    Weighted
Average
Exercise Price
 
Outstanding at January 1, 2020     589,125     $ 3.74  
Granted     255,000       2.09  
Exercised     (1,875 )     4.16  
Forfeited     (3,937 )     (12.14 )
Outstanding at December 31, 2020     838,313     $ 3.20  
Exercisable at December 31, 2020     725,813     $ 3.37  
Schedule of Fair Value of Stock Options Assumption

The Company has utilized the following assumptions in its Black-Scholes option valuation model to calculate the estimated grant date fair value of the options during the years ended December 31, 2020 and 2019:

 

    2020     2019  
    Assumptions     Assumptions  
Volatility – range     104 %     107.6 %
Risk-free rate     0.28 %     2.23 %
Contractual term     5.5 years       5.5 years  
Exercise price   $ 2.09     $ 3.01  
Schedule of Shares Authorized Under Stock Option Plans by Exercise Price Range

The following table summarizes the range of exercise prices and weighted average remaining contractual life for outstanding and exercisable options under the Company’s option plans as of December 31, 2020:

 

      Outstanding options   Exercisable options  
Exercise price
range
    Number of
options
    Weighted average
remaining
contractual life
  Number of
options
    Weighted average
remaining
contractual life
 
                         
$ 0.01 to $3.49       725,313     8.2 years     612,813       7.9 years  
$ 3.50 to $4.99       64,000     3.3 years     64,000       3.3 years  
$ 5.00 to $6.49           — years           —years  
$ 6.50 to $7.99       7,250     0.8 years     7,250       0.8 years  
$ 8.00 to $9.99       2,500     0.4 years     2,500       0.4 years  
$ 10.00 to $13.20       39,250     0.0 years     39,250       0.0 years  
                                 
                                 
          838,313     7.3 years     725,813       7.0 years  
Summary of Restricted Stock Activity

A summary of all restricted stock activity under the equity compensation plans for the years ended December 31, 2020 and 2019 is as follows:

 

    Number of
Restricted
shares
    Weighted
average
grant date
fair value
 
Nonvested balance, January 1, 2019     772,150     $ 3.40  
Granted     522,110       2.91  
Vested     (774,015 )     (3.35 )
Forfeited     (5,370 )     (3.46 )
Nonvested balance, December 31, 2019     514,875     $ 2.97  

 

 

    Number of
Restricted
shares
    Weighted
average
grant date
fair value
 
Nonvested balance, January 1, 2020     514,875     $ 2.97  
Granted     846,591       1.02  
Vested     (604,591 )     (1.85 )
Forfeited     (36,750 )     (1.84 )
Nonvested balance, December 31, 2020     720,125     $ 1.69  
Schedule of Non-vested Balance of Restricted Stock

The nonvested balance of restricted stock vests as follows:

 

Years ended   Number of
shares
 
       
2021     479,250  
2022     240,875